Cargando…
Muscle mass and physical function in patients with bladder cancer—Data from a prematurely terminated prospective cohort study
BACKGROUND: Patients with bladder cancer (BC) have a high prevalence of comorbidity and low adherence to systemic anticancer treatment but it is unknown whether this is associated with sarcopenia. OBJECTIVE: We aimed to investigate if the sarcopenia-defining parameters (muscle strength, muscle mass...
Autores principales: | Omland, Lise Høj, Ammitzbøll, Gunn, Lund, Cecilia Margareta, Lindberg, Henriette, Dalton, Susanne Oksbjerg, Suetta, Charlotte, Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582947/ https://www.ncbi.nlm.nih.gov/pubmed/36275921 http://dx.doi.org/10.3389/fresc.2022.942475 |
Ejemplares similares
-
Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020) -
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
por: Taarnhøj, Gry Assam, et al.
Publicado: (2020) -
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
por: Taarnhøj, Gry Assam, et al.
Publicado: (2019) -
PD‐L1 expression and FGFR‐mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study
por: Grantzau, Trine, et al.
Publicado: (2022) -
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020)